These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2928628)

  • 21. Analysis of toxic shock syndrome isolates producing staphylococcal enterotoxins B and C1 with use of southern hybridization and immunologic assays.
    Bohach GA; Kreiswirth BN; Novick RP; Schlievert PM
    Rev Infect Dis; 1989; 11 Suppl 1():S75-81; discussion S81-2. PubMed ID: 2494691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibody response to Staphylococcus aureus enterotoxins and TSST-1 in patients with septicaemia.
    Kanclerski K; Söderquist B; Kjellgren M; Holmberg H; Möllby R
    J Med Microbiol; 1996 Mar; 44(3):171-7. PubMed ID: 8636933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxic shock syndrome toxin 1 production.
    Schlievert PM; Blomster DA; Kelly JA
    Obstet Gynecol; 1984 Nov; 64(5):666-71. PubMed ID: 6436761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and purity assessment of toxic shock syndrome toxin 1.
    Rosten PM; Bartlett KH; Chow AW
    Rev Infect Dis; 1989; 11 Suppl 1():S110-5; discussion S115-6. PubMed ID: 2494689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever.
    Jarraud S; Cozon G; Vandenesch F; Bes M; Etienne J; Lina G
    J Clin Microbiol; 1999 Aug; 37(8):2446-9. PubMed ID: 10405382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1.
    Reeves MW
    Rev Infect Dis; 1989; 11 Suppl 1():S145-49; discussion S149-50. PubMed ID: 2928630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
    Dickgiesser N; Brombacher A; Wiest W
    Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):104-6. PubMed ID: 3569835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing.
    Altemeier WA; Lewis SA; Schlievert PM; Bergdoll MS; Bjornson HS; Staneck JL; Crass BA
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):978-82. PubMed ID: 6212008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits.
    de Azavedo JC; Arbuthnott JP
    Infect Immun; 1984 Nov; 46(2):314-7. PubMed ID: 6500691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ecology of toxic shock syndrome: amplification of toxic shock syndrome toxin 1 by materials of medical interest.
    Tierno PM; Hanna BA
    Rev Infect Dis; 1989; 11 Suppl 1():S182-6; discussion S186-7. PubMed ID: 2928635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent nonmenstrual toxic shock syndrome: clinical manifestations, diagnosis, and treatment.
    Andrews MM; Parent EM; Barry M; Parsonnet J
    Clin Infect Dis; 2001 May; 32(10):1470-9. PubMed ID: 11317249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
    Park JY; Kim JS; Woo H
    Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model.
    Sloane R; de Azavedo JC; Arbuthnott JP; Hartigan PJ; Kreiswirth B; Novick R; Foster TJ
    FEMS Microbiol Lett; 1991 Mar; 62(2-3):239-44. PubMed ID: 2040432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology of toxic shock syndrome toxin-1 production in Staphylococcus aureus strains isolated in Denmark between 1959 and 1990.
    Ejlertsen T; Jensen A; Lester A; Rosdahl VT
    Scand J Infect Dis; 1994; 26(5):599-604. PubMed ID: 7855557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of developing toxic shock syndrome associated with toxic shock syndrome toxin 1 following nongenital staphylococcal infection.
    Jacobson JA; Kasworm E; Daly JA
    Rev Infect Dis; 1989; 11 Suppl 1():S8-13. PubMed ID: 2928655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dilution rate and Mg2+ limitation on toxic shock syndrome toxin-1 production by Staphylococcus aureus grown in defined continuous culture.
    Taylor D; Holland KT
    J Gen Microbiol; 1988 Mar; 134(3):719-23. PubMed ID: 3183620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
    Schlievert PM
    J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.
    Pierson JD; Hansmann MA; Davis CC; Forney LJ
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
    Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
    Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.